Labcorp Holdings Earnings & Forecasts

Labcorp Holdings (LH) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

四半期利益の驚きの金額

会計四半期	報告日	実質EPS	推定EPS	驚き％
Q2	Jul 30, 2026	$4.99	$4.78	4.39 %
Q1	Apr 30, 2026	$4.25	$4.11	3.41 %
Q4	Feb 17, 2026	$4.07	$3.95	3.04 %
Q3	Oct 28, 2025	$4.18	$4.13	1.21 %

Quarterly Revenue (Billions)

四半期売上高の驚きの金額

会計四半期	報告日	実際の収益	推定収益	驚き％
Q2	Jul 30, 2026	$3.73B	$3.72B	0.43 %
Q1	Apr 30, 2026	$3.54B	$3.51B	0.87 %
Q4	Feb 17, 2026	$3.52B	$3.55B	-1.12 %
Q3	Oct 28, 2025	$3.56B	$3.56B	0.11 %

Labcorp Holdings Guidance

Labcorp Holdings (LH) は、9 10, 2026 年に fiscal year 2026 のガイダンスを最後に発表しました。同社は 1 株当たり利益を $18.1 - $18.55 の範囲と予想し、コンセンサス EPS 予想は $18.34 でした。Labcorp Holdings も、この期間の売上高を $14.71B - $14.83B の範囲と予想しました。

以前のガイダンスと比較すると、Labcorp HoldingsはEPS見通しを以前の範囲である維持から$18.1 - $18.55に引き上げました。売上高については、同社は売上高予測を以前の範囲である維持から$14.71B - $14.83Bに引き上げました。

Labcorp Holdingsは、19から10 27, 2022の間に9 10, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 6 times and lowered it 2 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$4.78	$4.11	$3.95	$4.13
Actual	$4.99	$4.25	$4.07	$4.18
Surprise	+4.39%	+3.41%	+3.04%	+1.21%
Revenue
Estimate	$3.72B	$3.51B	$3.55B	$3.56B
Actual	$3.73B	$3.54B	$3.52B	$3.56B
Surprise	+0.43%	+0.87%	-1.12%	+0.11%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$4.65	$4.45	$4.63	$5.27
Revenue
Consensus	$3.76B	$3.72B	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Labcorp Reaffirms 2026–2029 Long-Term Outlook Following CMS Preliminary Medicare Payment Rate Release; Expects Compound Annual Adj EPS Growth Of 8.5%-11.5% In 2026-2029

On September 21, 2026, the Centers for Medicare & Medicaid Services ("CMS") released preliminary Clinical Laboratory Fee Schedule payment rates applicable from 2027 through 2029 pursuant to the Protecting

Benzinga Newsdesk

Labcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029

Labcorp shares its strategic priorities and reaffirms 2026 guidance at its Investor Day, forecasting steady revenue growth through 2029.

Vandana Singh

PRO
Labcorp Provides Long-Term Outlook Through 2029, With 5%-8% Revenue CAGR And 8.5%-11.5% Adj EPS CAGR

Reaffirms full-year 2026 guidanceProvides long-term outlook through 2029, with compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share (EPS) growth of 8.5% to 11.5%Outlines strategic

Benzinga Newsdesk

PRO
Labcorp Holdings Affirms FY2026 Adj EPS Guidance of $18.10-$18.55 vs $18.01 Est; Affirms FY2026 Sales Guidance of $14.710B-$14.827B vs $14.707B Est

Labcorp Holdings (NYSE:LH) affirms FY2026 Adj EPS guidance from $18.10-$18.55 to $18.10-$18.55 vs $18.01 analyst estimate. Affirms FY2026 sales outlook from $14.710 billion-$14.827 billion to $14.710 billion-$14.827

Benzinga Newsdesk

PRO
Labcorp Holdings Raises FY2026 Adj EPS Guidance from $17.70-$18.35 to $18.10-$18.55 vs $18.01 Est; Raises FY2026 Sales Guidance from $14.650B-$14.800B to $14.710B-$14.827B vs $14.707B Est

Labcorp Holdings (NYSE:LH) raises FY2026 Adj EPS guidance from $17.70-$18.35 to $18.10-$18.55 vs $18.01 analyst estimate. Raises FY2026 sales outlook from $14.650 billion-$14.800 billion to $14.710 billion-$14.827

Benzinga Newsdesk

PRO
Laboratory Corp Q2 Adj. EPS $4.99 Beats $4.78 Estimate, Sales $3.731B Beat $3.711B Estimate

Laboratory Corp (NYSE:LH) reported quarterly earnings of $4.99 per share which beat the analyst consensus estimate of $4.78 by 4.39 percent. This is a 14.71 percent increase over earnings of $4.35 per share from the

Benzinga Newsdesk

Labcorp Holdings Inc